Innovative Business Models for Sustainable Growth in the Biotechnology Sector

Louis Bernard
University of Strasbourg, France.

Abstract:

Rapid change is sweeping through the biotechnology sector, fueled by innovations in genetic?engineering, synthetic biology, and precision medicine. data. 'Combining these macro trends present opportunities that require having sustainable business models?in place. The paper focuses on six types of strategies: platform-based strategies; bioeconomy and circular economy models;?subscription and outcome-based price models; open innovation strategies; decentralized biomanufacturing strategies; and AI strategies. This enables scaling, cost savings, and accessibility while ensuring?sustainability. Biotechnology companies that incorporate technological progress into collaborative ecosystems?can attain resilient and sustainable growth, placing them at the helm of scientific and economic progress. Such innovative business models are transforming biotechnology, rendering it more sustainable, scalable, and?fundable. Biotech firms that adopt these models across healthcare, agriculture, industry, and environmental sectors can leverage the?comparative advantage of multinational data development and drive technological advancements while contributing to the solution of global challenges. The biotechnology industry experiences industry changes through new business models that lead to operational improvements coupled with cost reductions and enhanced availability of advanced healthcare products. The biotech industry relies on platform-based approaches and AI-driven discovery and subscription-based treatments to achieve growth and technological innovations. These models will become essential in evolving biotech's future because ongoing technological development enables the creation of transformative therapies and sustainable solutions against world problems.